Cargando…

Selective reporting in trials of high risk cardiovascular devices: cross sectional comparison between premarket approval summaries and published reports

Objective To investigate characteristics of clinical trials and results on safety and effectiveness reported in US Food and Drug Administration (FDA) documents for recently approved high risk cardiovascular devices compared with the characteristics and results reported in peer reviewed publications....

Descripción completa

Detalles Bibliográficos
Autores principales:	Chang, Lee, Dhruva, Sanket S, Chu, Janet, Bero, Lisa A, Redberg, Rita F
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group Ltd. 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4462712/ https://www.ncbi.nlm.nih.gov/pubmed/26063311 http://dx.doi.org/10.1136/bmj.h2613

Ejemplares similares

Market competition among manufacturers of novel high-risk therapeutic devices receiving FDA premarket approval between 2001 and 2018
por: Rathi, Vinay K, et al.
Publicado: (2023)

Changing FDA Approval Standards: Ethical Implications for Patient Consent
por: Darrow, Jonathan J., et al.
Publicado: (2021)

Medical Device Regulation: Time to Improve Performance
por: Dhruva, Sanket S., et al.
Publicado: (2012)

Overview of the Premarketing and Postmarketing Requirements for Drugs Granted Japanese Conditional Marketing Approval
por: Matsushita, Shunsuke, et al.
Publicado: (2021)

Quantification of US Food and Drug Administration Premarket Approval Statements for High-Risk Medical Devices With Pediatric Age Indications
por: Lee, Samuel J., et al.
Publicado: (2021)

Cardiovascular Safety Profile of Dapoxetine during the Premarketing Evaluation
por: Kowey, Peter R., et al.
Publicado: (2012)

Postmarket Clinical Evidence for High-Risk Therapeutic Medical Devices Receiving Food and Drug Administration Premarket Approval in 2010 and 2011
por: Rathi, Vinay K., et al.
Publicado: (2020)

Left to Their Own Devices: Breakdowns in United States Medical Device Premarket Review
por: Hines, Jonas Zajac, et al.
Publicado: (2010)

Risk of Recall Among Medical Devices Undergoing US Food and Drug Administration 510(k) Clearance and Premarket Approval, 2008-2017
por: Dubin, Jonathan R., et al.
Publicado: (2021)

Premarket Approval Through the 510(k) Process: Lessons from the Translation Process of Magnetic Resonance Elastography
por: Aponte Ortiz, Jaime A., et al.
Publicado: (2018)

Cardiac coronary tomography angiography (CCTA) use across geographical regions in the USA and the UK: a cross-sectional study
por: Banashefski, Bryana, et al.
Publicado: (2023)

Premarket Safety and Efficacy Studies for ADHD Medications in Children
por: Bourgeois, Florence T., et al.
Publicado: (2014)

Assessing Visual Outcomes: A Comparative Study of US-FDA Premarket Approval Data for Multifocal and EDOF Lens Implants in Cataract Surgery
por: Moshirfar, Majid, et al.
Publicado: (2023)

Recent progress to shorten premarket evaluation and improve patient access to medical devices by the Pharmaceuticals and Medical Devices Agency of Japan
por: Handa, Nobuhiro, et al.
Publicado: (2019)

Collaboration between academics and industry in clinical trials: cross sectional study of publications and survey of lead academic authors
por: Rasmussen, Kristine, et al.
Publicado: (2018)

Premarket evaluation of medical devices: a cross-sectional analysis of clinical studies submitted to a German ethics committee
por: Sauerland, Stefan, et al.
Publicado: (2019)

Reporting of Study Participant Demographic Characteristics and Demographic Representation in Premarketing and Postmarketing Studies of Novel Cancer Therapeutics
por: Varma, Tanvee, et al.
Publicado: (2021)

Coverage of Novel Therapeutic Agents by Medicare Prescription Drug Plans Following FDA Approval
por: Shaw, Daniel L., et al.
Publicado: (2018)

Seventh Annual Report Summary Published
Publicado: (1995)

Evidence supporting FDA approval and CMS national coverage determinations for novel medical products, 2005 through 2016: A cross-sectional study
por: Roginiel, Aliya C., et al.
Publicado: (2018)

Postmarketing commitments for novel drugs and biologics approved by the US Food and Drug Administration: a cross-sectional analysis
por: Wallach, Joshua D., et al.
Publicado: (2019)

Summary of approved PS counter experiments
por: Weilhammer, P
Publicado: (1974)

Summary of approved PS counter experiments
por: Beusch, W
Publicado: (1973)

Analysis of Postapproval Clinical Trials of Therapeutics Approved by the US Food and Drug Administration Without Clinical Postmarketing Requirements or Commitments
por: Skydel, Joshua J., et al.
Publicado: (2019)

Status report on approved Omega experiments and summary of new proposals with tentative schedule for 1974
por: Dowell, John D
Publicado: (1974)

Time Series Analysis of the Effectiveness and Safety of Capsule Endoscopy between the Premarketing and Postmarketing Settings: A Meta-Analysis
por: Iijima, Kazuo, et al.
Publicado: (2016)

Premarket Development Times for Innovative Vaccines––To What Extent Are the Coronavirus Disease 2019 (COVID-19) Vaccines Outliers?
por: Beall, Reed F, et al.
Publicado: (2021)

Summary of approved experiments PS counter experiments
por: Darriulat, P
Publicado: (1972)

Consistency of trial reporting between ClinicalTrials.gov and corresponding publications: one decade after FDAAA
por: Talebi, Ramtin, et al.
Publicado: (2020)

Characterization of US Food and Drug Administration Class I Recalls from 2018 to 2022 for Moderate- and High-Risk Medical Devices: A Cross-Sectional Study
por: Mooghali, Maryam, et al.
Publicado: (2023)

‘Spin’ in published biomedical literature: A methodological systematic review
por: Chiu, Kellia, et al.
Publicado: (2017)

P1 publishable summary
por: The HiLumi LHC Collaboration
Publicado: (2013)

Physical activity, patient-reported symptoms, and clinical events: Insights into postprocedural recovery from personal digital devices
por: Bartlett, Victoria L., et al.
Publicado: (2021)

The premarket assessment of the cost-effectiveness of a predictive technology “Straticyte™” for the early detection of oral cancer: a decision analytic model
por: Khoudigian-Sinani, S., et al.
Publicado: (2017)

Accurate estimation of cardiovascular risk in a non-diabetic adult: detecting and correcting the error in the reported Framingham Risk Score for the Systolic Blood Pressure Intervention Trial population
por: Warner, Frederick, et al.
Publicado: (2018)

Association of trial registration with the results and conclusions of published trials of new oncology drugs
por: Rasmussen, Nicolas, et al.
Publicado: (2009)

Papillary Ependymoma of the Spinal Cord: A Case Report with Summary of Prior Published Cases
por: Chaudhuri, Priyanka Maity, et al.
Publicado: (2019)

China cardiovascular diseases report 2015: a summary
por: CHEN, Wei-Wei, et al.
Publicado: (2017)

China cardiovascular diseases report 2018: an updated summary
por: Ma, Li-Yuan, et al.
Publicado: (2020)

Use of Mechanical Cardiopulmonary Resuscitation Devices for Out-of-Hospital Cardiac Arrest, 2010-2016
por: Kahn, Peter A., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ka8vavoill94f6hc82im9kcv90